{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:13:09Z","timestamp":1771650789800,"version":"3.50.1"},"reference-count":22,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"unspecified","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"CHRU de Nancy","award":["CPRC, 2nd appel 2021"],"award-info":[{"award-number":["CPRC, 2nd appel 2021"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,6,4]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pre-eclampsia and fetal growth restriction (FGR) are two principal complications of pregnancy related to placental dysfunction. Nevertheless, knowledge of the underlying pathophysiological mechanisms remains inadequate, and only a few tools are available for in vivo assessment of placental perfusion. Contrast-enhanced ultrasound (CEUS) allows organ vascularisation evaluation via a strictly intravascular gas microbubble. The primary aim of this study is to compare placental vascularisation parameters obtained via CEUS between pregnancies with FGR and those without FGR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a single-centre, prospective, comparative, non-randomised, feasible, open and interventional study. We will include 30\u2009women with medical termination of pregnancy divided into two groups: one with severe FGR and the other without FGR. Severe FGR is defined as an estimated fetal weight below the third percentile for gestational age. Women will be informed and recruited in the fetal medicine unit over a period of 48 months. The primary goal of this study is to compare the placental contrast ultrasound parameter measurements according to group. The primary objective is to compare placental contrast ultrasound data in women who undergo medical termination of pregnancy at a gestational age of 16 weeks (38+6 days) between two groups: a group with FGR and a group without FGR. The secondary objectives are as follows: (1) to describe the placental vascularisation parameters measured by CEUS; (2) to describe the parameters for quantifying vascularisation at different gestational ages via CEUS; (3) to study the associations between CEUS data and placental histological data and (4) to establish a biological collection of placentas to increase our knowledge of the development and functions of the placenta during pregnancy. The statistical analysis will include descriptive analysis for all study patients, with quantitative data described by means\u00b1SDs, medians, IQRs, and extreme values and qualitative data reported as counts and percentages. Comparisons of placental contrast ultrasound parameters between the two groups will be performed via Student\u2019s t-test or the Mann-Whitney U test on the basis of data normality. Associations between CEUS parameters and placental histology data will be analysed with Spearman or Pearson correlations. Qualitative associations will be studied via analysis of variance or the Kruskal-Wallis test. Box plot representations will be used when applicable. Analyses will be performed with R software, with significance set at p&lt;0.05.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study was approved by the French Ethics Committee, the CPP (Comit\u00e9 de Protection des Personnes) SUD EST II \u2013 LYON \u2013 FRANCE, on 26 April 2024, with reference number 2023-506936-34-00, and the competent authority ANSM (Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9) authorised the study on 17 May 2024. The results of this study will be published in a peer-reviewed journal and will be presented at relevant conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration numbers<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06497959\">NCT06497959<\/jats:ext-link>\n                      ; EU CT number: 2023-506936-34-00.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-093090","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T02:35:59Z","timestamp":1754879759000},"page":"e093090","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Contributions of contrast-enhanced ultrasound (CEUS) to a fetal\u2013placental circulation study (EVUPACUS): a protocol for a prospective comparative study in a population of women undergoing termination of pregnancy"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct06497959","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0107-9868","authenticated-orcid":false,"given":"Juliette","family":"Lefebvre","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Fetal Medicine, Nancy University Hospital, Nancy, France"},{"name":"IADI INSERM-U1254, Nancy University Hospital, Vand\u0153uvre-l\u00e8s-Nancy, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aboubaker","family":"Cherifi","sequence":"additional","affiliation":[{"name":"CIC, Innovation Technologique, Universit\u00e9 de Lorraine, Nancy University Hospital, Nancy, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Hossu","sequence":"additional","affiliation":[{"name":"IADI INSERM-U1254, Nancy University Hospital, Vand\u0153uvre-l\u00e8s-Nancy, France"},{"name":"CIC, Innovation Technologique, Universit\u00e9 de Lorraine, Nancy University Hospital, Nancy, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3547-9889","authenticated-orcid":false,"given":"Anne-Laure","family":"Fijean","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Fetal Medicine, Nancy University Hospital, Nancy, France"},{"name":"IADI INSERM-U1254, Nancy University Hospital, Vand\u0153uvre-l\u00e8s-Nancy, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Morel","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Fetal Medicine, Nancy University Hospital, Nancy, France"},{"name":"IADI INSERM-U1254, Nancy University Hospital, Vand\u0153uvre-l\u00e8s-Nancy, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charline","family":"Bertholdt","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Fetal Medicine, Nancy University Hospital, Nancy, France"},{"name":"IADI INSERM-U1254, Nancy University Hospital, Vand\u0153uvre-l\u00e8s-Nancy, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Beaumont","sequence":"additional","affiliation":[{"name":"CIC, Innovation Technologique, Universit\u00e9 de Lorraine, Nancy University Hospital, Nancy, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2846-1509","authenticated-orcid":false,"given":"Matthieu","family":"Dap","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Fetal Medicine, Nancy University Hospital, Nancy, France"},{"name":"IADI INSERM-U1254, Nancy University Hospital, Vand\u0153uvre-l\u00e8s-Nancy, France"},{"name":"Department of Foetopathology and Placental Pathology, Nancy University Hospital, Nancy, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,8,10]]},"reference":[{"key":"2025123106455265000_15.8.e093090.1","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/AOG.0000000000003070","article-title":"ACOG Practice Bulletin no.204: Fetal Growth Restriction","volume":"133","year":"2019","journal-title":"Obstet Gynecol F\u00e9vr"},{"key":"2025123106455265000_15.8.e093090.2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex301"},{"key":"2025123106455265000_15.8.e093090.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.11.577"},{"key":"2025123106455265000_15.8.e093090.4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l2381","article-title":"Pre-eclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ"},{"key":"2025123106455265000_15.8.e093090.5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jgyn.2013.09.011","article-title":"Intra uterine growth retardation: guidelines for clinical practice--Method and organization","volume":"42","author":"Vayssi\u00e8re","year":"2013","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"2025123106455265000_15.8.e093090.6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.07.050","article-title":"What is the placenta?","volume":"213","author":"Burton","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"2025123106455265000_15.8.e093090.7","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2015-0225-CC"},{"key":"2025123106455265000_15.8.e093090.8","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajog.2015.08.037","article-title":"The human placenta project: it\u2019s time for real time","volume":"213","author":"Guttmacher","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"2025123106455265000_15.8.e093090.9","doi-asserted-by":"publisher","DOI":"10.2144\/btn-2020-0069"},{"key":"2025123106455265000_15.8.e093090.10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.placenta.2024.02.004","article-title":"Evaluation of utero-placental vascularization using contrast-enhanced ultrasound: Early first trimester maternal perfusion of the intervillous space is confirmed","volume":"148","author":"Bertholdt","year":"2024","journal-title":"Placenta"},{"key":"2025123106455265000_15.8.e093090.11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.placenta.2013.08.002","article-title":"Decrease of uteroplacental blood flow after feticide during second-trimester pregnancy termination with complete placenta previa: quantitative analysis using contrast-enhanced ultrasound imaging","volume":"34","author":"Poret-Bazin","year":"2013","journal-title":"Placenta"},{"key":"2025123106455265000_15.8.e093090.12","doi-asserted-by":"publisher","DOI":"10.1053\/plac.1998.0369"},{"key":"2025123106455265000_15.8.e093090.13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000020993","article-title":"Contrast-enhanced ultrasonography of uteroplacental circulation does not evoke harmful CTG changes or perinatal events","volume":"15","author":"Ord\u00e9n","year":"2000","journal-title":"Fetal Diagn Ther"},{"key":"2025123106455265000_15.8.e093090.14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/a-0973-8517","article-title":"Single-Center Study: Evaluating the Diagnostic Performance and Safety of Contrast-Enhanced Ultrasound (CEUS) in Pregnant Women to Assess Hepatic Lesions","volume":"41","author":"Schwarze","year":"2020","journal-title":"Ultraschall in Med"},{"key":"2025123106455265000_15.8.e093090.15","first-page":"675","article-title":"Contrast-Enhanced Ultrasound for Assessing Abdominal Conditions in Pregnancy","volume":"56","author":"Geyer","year":"2020","journal-title":"Med Bogota Colomb"},{"key":"2025123106455265000_15.8.e093090.16","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017741","article-title":"Efficacy of contrast-enhanced ultrasound for diagnosis of cesarean scar pregnancy type","volume":"98","author":"Wu","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2025123106455265000_15.8.e093090.17","unstructured":"Fetal vascular malperfusion, an update - Redline - 2018 - APMIS - Wiley Online Library, Available: https:\/\/onlinelibrary-wiley-com.proxy.insermbiblio.inist.fr\/doi\/10.1111\/apm.12849"},{"key":"2025123106455265000_15.8.e093090.18","unstructured":"Maternal vascular malperfusion of the placental bed - Ernst - 2018 - APMIS - Wiley Online Library, Available: https:\/\/onlinelibrary-wiley-com.proxy.insermbiblio.inist.fr\/doi\/10.1111\/apm.12833"},{"key":"2025123106455265000_15.8.e093090.19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/10935266211008444","article-title":"Formulating a Meaningful and Comprehensive Placental Phenotypic Classification","volume":"24","author":"Freedman","year":"2021","journal-title":"Pediatr Dev Pathol"},{"key":"2025123106455265000_15.8.e093090.20","doi-asserted-by":"crossref","unstructured":"Khong TY , Mooney EE , Nikkels PGJ , et al . Pathology of the placenta: a practical guide. Cham: Springer International Publishing, 2019.","DOI":"10.1007\/978-3-319-97214-5"},{"key":"2025123106455265000_15.8.e093090.21","doi-asserted-by":"publisher","DOI":"10.1002\/uog.15884"},{"key":"2025123106455265000_15.8.e093090.22","unstructured":"Investigational device exemptions (ides) for early feasibility medical device clinical studies, including certain first in human (fih) studies. 2020. Available: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/investigational-device-exemptions-ides-early-feasibility-medical-device-clinical-studies-including"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-093090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:46:36Z","timestamp":1767192396000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-093090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,10]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/bmjopen-2024-093090"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-093090","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}